Group items tagged

Encyclopedia section of medindia explains about the treatment for Urinary stone disease

PBR Staff Writer Published 25 February 2014 Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment of genotype 1b chronic hepatitis C infection (HCV).

Breast changes, such as lumps are common in women. Keeping the threat of breast cancer in mind every lump should be medically evaluated.